BenevolentAI
Pre-clinicalBenevolentAI (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery.
Founded
2013
Focus
AI / Machine Learning
About
BenevolentAI (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery.
Funding History
7Total raised: $760M
PIPE$150MUndisclosedMar 15, 2022
Series C$90MVNV GlobalMar 15, 2021
Series B$115MTemasek HoldingsMay 15, 2018
Series C$90MTemasek HoldingsApr 15, 2018
Company Info
TypePrivate
Founded2013
LocationLondon, United Kingdom
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile